• Français
  • English
  • Necker Biotherapy Center

Biotherapy for Innovation in Orphan Disease

Biotherapy for Innovation in Orphan Disease

  • Necker Biotherapy Center
Actualités : Presse, Congrès & Publications scientifiquesScientific publications

Scientific publications

Scientific publications 1 January 2021

Bayesian Modeling Immune Reconstitution Apply to CD34+ Selected Stem Cell Transplantation for Severe Combined Immunodeficiency.

Severe combined immunodeficiencies (SCIDs) correspond to the most severe form of primary immunodeficiency. Allogeneic hematopoietic stem cell transplantation (HSCT) and gene therapy are curative treatments, depending on the donor's availability and molecular diagnostics. A partially human leukocyte antigen (HLA)-compatible donor [...]

  • Necker Biotherapy Center
  • Necker Biotherapy Center
  • Necker Biotherapy Center
© copyright 2026 - Hôpital Necker / Institut Imagine / Necker Biotherapy Center